News

A Simpler Delivery: FDA Approves Subcutaneous Injection Version of Powerful Targeted Drug Isatuximab for Multiple Myeloma

Jul 20, 2026 in Multiple Myeloma

‘Good Morning America’ Michael Strahan On the Impact His Daughter's Brain Cancer Diagnosis Had on Him

Jul 19, 2026 in Glioma

Planning the Treatment Journey: How Doctors Sequence Therapies in CLL

Jul 17, 2026

BTK Inhibitors & Beyond: Emerging Research And Treatment Options For CLL

Jul 16, 2026

BTK Inhibitors: Uses and Limitations in CLL Treatment

Jul 16, 2026

New Approval Means More Bladder Cancer Patients Can Access Powerful Immunotherapy Combination, Keytruda + Padcev

Jul 15, 2026 in Bladder Cancer

For The First Time, A Potential Treatment Option For All Uveal Melanoma Patients

Jul 13, 2026 in Melanoma

From Chemotherapy to Targeted Pills: A New Era in Chronic Myeloid Leukemia and What Asciminib Could Mean for Patients

Jun 30, 2026

FDA Approves Ibrance Combination as New Maintenance Option for HR+/HER2+ Metastatic Breast Cancer

Jun 29, 2026 in Breast Cancer

New FDA Approval May Help Reduce the Risk of Kidney Cancer Returning After Surgery-- What Patients Need To Know About Welireg

Jun 29, 2026

Better Options for Treating Anemia in Lower-Risk Myelodysplastic Syndrome

Jun 26, 2026

Daejin Abidoye On AbbVie's Mission: "Finding the Right Patient for the Right Drug at the Right Time"

Jun 26, 2026